Assessment of Liver Cancer Burden from 1990 to 2021 with Projections for 2040: Findings from the 2021 Global Burden of Disease Study - Scorecard - MDSpire
Advertisement
Assessment of Liver Cancer Burden from 1990 to 2021 with Projections for 2040: Findings from the 2021 Global Burden of Disease Study
Clinical Scorecard: Assessment of Liver Cancer Burden from 1990 to 2021 with Projections for 2040: Findings from the 2021 Global Burden of Disease Study
At a Glance
Category
Detail
Condition
Key Mechanisms
Non-alcoholic steatohepatitis (NASH), hepatitis B virus (HBV), hepatitis C virus (HCV), alcohol consumption, metabolic syndrome.
Target Population
Care Setting
Key Highlights
In 2021, global incident cases of liver cancer totaled over 2 million, with specific breakdowns for each subtype.
Guideline-Based Recommendations
Diagnosis
Management
Integrate public health measures with clinical interventions to address liver cancer, including specific strategies for HBV and HCV.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Focus on interdisciplinary collaboration for effective management, including specific treatment options.
Clinical Best Practices
Strengthen screening and prevention strategies for high-risk populations, including specific examples.
